These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16722150)

  • 1. [Molecular biology and diabetes: where to now?].
    Haluzík M
    Vnitr Lek; 2006 Mar; 52(3):205-6. PubMed ID: 16722150
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 3. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B; Abreu-Pacheco H
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract]   [Full Text] [Related]  

  • 4. Maturity onset diabetes of the young.
    Vijay V; Yunus B; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1995 Mar; 43(3):211-2. PubMed ID: 11256912
    [No Abstract]   [Full Text] [Related]  

  • 5. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative activity of the gastric epithelium: changes due to therapy in patients with association of gastric ulcer and diabetes mellitus].
    Fedorchenko IuL; Goncharova EN; Koblova NM
    Khirurgiia (Mosk); 2001; (6):43-6. PubMed ID: 11517701
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA; Darby-Stewart A; Dachs R
    Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient characteristics not described.
    Lofsky S
    CMAJ; 2006 Jun; 174(13):1874. PubMed ID: 16785468
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Rand L; Caughey AB
    Am J Obstet Gynecol; 2006 Aug; 195(2):628-9; author reply 629-30. PubMed ID: 16579949
    [No Abstract]   [Full Text] [Related]  

  • 11. Initiating insulin in type 2 diabetes.
    Ravina A
    Isr Med Assoc J; 2004 Dec; 6(12):787. PubMed ID: 15609901
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
    Räkel A; Renier G; Roussin A; Buithieu J; Mamputu JC; Serri O
    Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
    [No Abstract]   [Full Text] [Related]  

  • 13. [Type 2 diabetes: when and how to start insulin treatment?].
    Philippe J
    Rev Med Suisse Romande; 2004 Mar; 124(3):129-32. PubMed ID: 15095654
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of type 2 diabetes: the role for new agents.
    Taylor R
    Int J Clin Pract Suppl; 1999 Jul; 104():14-7; discussion 18-20. PubMed ID: 12669733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions].
    Matthaei S
    MMW Fortschr Med; 2007 Apr; 149(15):53. PubMed ID: 17668779
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for insulin management of diabetes in school.
    Silverstein J; Patrick S
    School Nurse News; 2007 Mar; 24(2):9-12. PubMed ID: 17393819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early insulin administration in obese patients with type 2 diabetes makes sense--contra].
    Schusdziarra V
    Dtsch Med Wochenschr; 2008 Apr; 133(17):920. PubMed ID: 18415918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early insulin administration in obese patients with type 2 diabetes makes sense--pro].
    Dreyer M
    Dtsch Med Wochenschr; 2008 Apr; 133(17):919. PubMed ID: 18415917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.